NCT07337980

Brief Summary

The aim of this study is to explore the safety and efficacy of endoscopic surgery in the treatment of extraluminal growing stromal tumors

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
8mo left

Started Jan 2026

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress35%
Jan 2026Dec 2026

Study Start

First participant enrolled

January 1, 2026

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

January 3, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

January 13, 2026

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 12, 2026

Expected
19 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

January 13, 2026

Status Verified

January 1, 2026

Enrollment Period

12 months

First QC Date

January 3, 2026

Last Update Submit

January 3, 2026

Conditions

Keywords

endoscopic surgeryinterstitialoma

Outcome Measures

Primary Outcomes (1)

  • Complete resection rate

    Complete resection rate of extraluminal growing stromal tumors

    12 months

Secondary Outcomes (1)

  • Recurrence-free survival

    12 months

Study Arms (1)

Endoscopic-surgery Group

Patients with extraluminal growing stromal tumors undergoing endoscopic treatment

Procedure: Extraluminal growing stromal tumors treated endoscopically

Interventions

To observe the safety and efficacy of endoscopic treatment of extraluminal growing stromal tumors

Endoscopic-surgery Group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with gastric stromal tumor with extraluminal growth

You may qualify if:

  • (1) CT scan showed extramural protrusion of the stomach (2) ultrasonic endoscopy revealed submucosal tumors with extra-gastric growth; (3) patients received ESD/EFTR or surgical treatment

You may not qualify if:

  • (1) patients had malignant tumors in the stomach or had undergone stomach surgery (2) follow-up records were incomplete.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Ruihua Shi, Ph.D

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
12 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 3, 2026

First Posted

January 13, 2026

Study Start

January 1, 2026

Primary Completion (Estimated)

December 12, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

January 13, 2026

Record last verified: 2026-01